0% found this document useful (0 votes)
59 views1 page

BC266

The document reports the results of a fecal calprotectin test for a patient. The test result of 150.0 H is elevated. Fecal calprotectin is used to detect inflammation in the gut and distinguish inflammatory bowel disease from other conditions.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
59 views1 page

BC266

The document reports the results of a fecal calprotectin test for a patient. The test result of 150.0 H is elevated. Fecal calprotectin is used to detect inflammation in the gut and distinguish inflammatory bowel disease from other conditions.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Client Processed By

Gurugram Pathkind Diagnostics Pvt. Ltd.


Pathkind Diagnostics Pvt. Ltd. Plot No. 55-56, Udhyog Vihar Ph-IV, Gurugram - 122015
Plot No. 55-56, Udhyog Vihar Ph-IV, Gurugram - 122015

Name : Mr. BC266 Billing Date : 07/07/2023 12:11:23


Age : 35 Yrs Sample Collected on : 10/07/2023 10:01:31
Sex : Male Sample Received on : 10/07/2023 11:02:13
P. ID No. : P1000100012380 Report Released on : 15/07/2023 16:52:50
Accession No : 10002304436 Barcode No. : 10002304436-01
Referring Doctor : Self
Referred By : Ref no. :

Report Status - Final


Test Name Result Biological Ref. Interval Unit

SEROLOGY
Fecal Calprotectin 150.0 H Normal: <50 µg/g
Sample: Stool Borderline: 50 - 120
Method: CLIA Elevated: >120

Fecal Calprotectin

Test Description:
1. Calprotectin is a calcium-binding protein secreted predominantly by neutrophils and monocytes.
2. Fecal calprotectin is a direct measure of inflammation in the gut and is directly correlates to disease activity in Inflammatory Bowel
Disease (IBD).
3. Elevations can be caused by IBD, infection, polyps,neoplasia or NSAID usage.
4. Fecal calprotectin assay has a relatively high specificity and sensitivity (approximately 90%) for distinguishing between
noninflammatory bowel disorders (e.g. irritable bowel syndrome) and inflammatory bowel disease (e.g. ulcerative colitis and Crohn`s
disease). Therefore allows for clear distinction of both the diseases.
5. Calprotectin is also elevated in some cases of GI tract malignancy (e.g. colorectal cancer).
6. It is regularly raised in active IBD
7. Faecal calprotectin concentrations relate well to disease activity in the inflammatory bowel diseases and can therefore be used to monitor
therapy

Limitations :
1. Other intestinal ailments, including GI infections and colorectal cancer, can result in elevated concentrations of fecal calprotectin
2. Diagnosis of IBD cannot be established solely on the basis of a abnormal calprotectin results.
3. Patients with IBD fluctuate between active and inactive stages of disease. Hence fecal calprotectin results may also fluctuate
4. GI bleeding of as much as 100 mL per day will increase the fecal calprotectin levels by only 15 μg/g.

** End of Report**

Dr. Saloni Garg


MD
Consultant Microbiology

10002304436 Mr. BC266


Page No: 1 of 1

You might also like